帕金森病患者的肌酸加权成像
Kexin Wang1,2, Nirbhay Narayan Yadav1,3, Zijiang Yang1,4
1F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, MD, USA.
NPJ Parkinson's disease
|December 13, 2025
概括
这项研究使用GuanCESTMRI测量帕金森病 (PD) 患者的肌酸水平,发现大脑中的水平较低. 这些水平与疾病严重程度相关,这表明GuanCEST MRI是PD的潜在生物标志物.
科学领域:
- 神经成像是一种神经成像.
- 生物化学 生物化学
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 涉及大脑能量代谢受损和线粒体功能障碍.
- 补充肌酸 (Cr) 是一种潜在的治疗方法,但不一致的临床结果阻碍了其应用.
- 测量大脑的Cr分布是具有挑战性的,限制了研究.
研究的目的:
- 为了利用瓜尼迪诺化学交换和转移 (GuanCEST) MRI 来评估PD患者的区域Cr水平.
- 调查Cr水平与PD严重程度之间的关系.
- 建立GuanCESTMRI作为PD中Cr代谢的非侵入性生物标志物.
主要方法:
- 采用了GuanCESTMRI,一种新的神经成像技术.
- 招募了25名患有PD (PwPD) 的患者和24名健康对照 (HC).
- 分析了特定大脑区域的区域 GuanCEST 值,例如尾状核和丘脑.
主要成果:
- 与HC相比,在PwPD的尾状核中观察到明显较低的GuanCEST值 (表明减少的Cr).
- GuanCEST信号的减少与PD严重程度的增加相关,特别是在thalamic亚区域.
- 在内部髓膜和MDS-UPDRS-III得分中的GuanCEST值之间发现了负相关性,这表明Cr降低与PD严重程度更高.
结论:
- 在GuanCEST的MRI中显示,作为评估PD中Cr代谢的非侵入性生物标志物具有前途.
- 这种技术可以提供对PD机制的见解,并有助于优化治疗策略.
- 通过提供可测量的结果,GuanCEST MRI可能会增强PD的临床试验设计.
更多相关视频
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
12.1K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.1K
相关概念视频
01:24Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K